Japan says in deal to purchase AstraZeneca's COVID-10 vaccine

  • Japan says in deal to purchase AstraZeneca's COVID-10 vaccine

Japan says in deal to purchase AstraZeneca's COVID-10 vaccine

Should the shot cross the regulatory finish line, AstraZeneca will begin deployment to Japan next year, with an initial 30 million doses expected by March, Tokyo-based Kyodo News said.

Last week, Sanofi and GlaxoSmithKline signed a deal with the USA government to produce 100 million doses of a vaccine for about $10.50 each, according to calculations from analyst Mani Foroohar, of the brokerage firm SVB Leerink.

In a statement, AstraZeneca said it would produce the vaccine substance in Japan with JCR Pharmaceuticals Co, while also importing additional substance from overseas.

Daiichi Sankyo Biotech and KM Biologics will undertake production, such as filling vials and packaging, while Daiichi Sankyo and Meiji Seika Pharma will support shipping.

Coronavirus vaccine developer Moderna Inc (NASDAQ: MRNA) has struck its first deal with a government agency, as Switzerland confirmed Friday reports of procuring the mRNA vaccine developed by the company against SARS-CoV-2, Reuters reported. It's also a major supplier of hepatitis B vaccine.

Meanwhile, Pfizer has said it will price its vaccine at $19.50 per dose.

On the same day, U.S. Food and Drug Administration Commissioner Stephen Hahn said the country will need to have independent experts review COVID-19 vaccine candidates before approval.

Japan is the latest country to sign up for AstraZeneca's vaccine, known as AZD1222, which is under development in partnership with the University of Oxford.

"If each person receives two injections, this would cover 60 million people". Takeda will receive government funding to scale up its shot-making brawn, with expected capacity for 250 million doses of Novavax's jab per year. Under the global inoculation drive, AstraZeneca has already eked out massive orders in a number of regions, pledging 300 million doses apiece to the USA and the European Union, along with 100 million doses for the United Kingdom and another hundred million to Brazil.